Login / Signup

Evaluation of irrational dose assignment definitions using the continual reassessment method.

Nolan A WagesEvan Bagley
Published in: Clinical trials (London, England) (2019)
Zhou and colleagues argue that the behavior of the continual reassessment method is disturbing due to its ability to make irrational dose assignments. These definitions are based on rules that mimic the popular 3 + 3 design, which should not be the benchmark used to construct guidelines for trial conduct of modern Phase I methods. Our study illustrates that these dose assignments occur very seldom in the continual reassessment method and that even when they do occur, they can often be considered sensible when accounting for all accumulated data in the study.
Keyphrases
  • clinical trial
  • randomized controlled trial
  • study protocol
  • clinical practice
  • machine learning
  • phase iii
  • phase ii